The global ambulatory blood pressure monitoring devices market size is expected to reach USD 2.63 billion by 2030, expanding at a CAGR of 11.6% from 2024 to 2030, according to a new study by Grand View Research, Inc. The driving factors accelerating the growth of this market include the increasing geriatric population, the prevalence of chronic disorders such as hypertension, and technological advancement worldwide. According to the statistics published by WHO, around 1.13 billion people are likely to suffer from hypertension and causing 7.6 million deaths annually.
In addition, high blood pressure is a major risk factor for hemorrhagic stroke and coronary heart disease in this decade. For instance, as per WHO, an estimated 1.28 billion adults who are aged between 30-79 years globally suffer from hypertension, whereas 42.0% of the adults having hypertension are not aware that they have the condition. Hypertension, besides being the most prevalent, is also the leading cause of cardiovascular disease, premature mortality, and disability. It poses a significant economic burden.
Aging population is another driving factor accelerating the growth of the market. As per the recent WHO statistical data published in October 2022, 1 in 6 people would be over 60 years of age worldwide by 2030 and this number would be doubled by 2050. Moreover, cardiovascular diseases are highly prevalent in the older age population.
Also, technological advancement in ambulatory blood pressure monitoring (ABPM) devices is likely to boost the market over the forecast period. Manufacturing of digital technology-based and mobile blood pressure devices fueling the demand of consumers. Key players in the market consistently focus on the development of cost-friendly, innovative, and easy-to-use devices is likely to strengthen the demand of the market.
Request a free sample copy or view report summary: Ambulatory Blood Pressure Monitoring Devices Market Report
Based on the product, instrument & accessories dominated the market and accounted for 67.5 % of global revenue in 2023 owing to constant technological advancements such as improvements in wearable technology, apps, & mobiles, their accessibility, and simplicity in usage
Based on the type, the blood pressure cuff segment dominated the market with a revenue share of 56.3% in 2023 due to higher accuracy, reliability of data collection, and flexibility in usage provided by blood cuff
Based on the end-use, ambulatory surgical centers & clinics accounted for largest share of 63.7 % of the ABPM devices market in 2023 owing to increasing number of ambulatory surgeries due to short duration of stay and cost savings
Based on Based on the region, North America dominated the global ABPM devices market with a revenue share of 39.5 in 2023 owing to increase in product launches by key companies, rising overall healthcare expenditure, and an increase in several regulatory approvals
Grand View Research has segmented the global ambulatory blood pressure monitoring devices market based on product, type, end-use, and region:
ABPM Devices Product Outlook (Revenue, USD Million, 2018 - 2030)
Ambulatory Blood Pressure Monitors
Instrument & Accessories
Blood Pressure Cuffs
Others Type
ABPM Devices Type Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Ambulatory Surgical Centres & Clinics
Homecare
ABPM Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
South Korea
Australia
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Ambulatory Blood Pressure Monitoring (ABPM) Devices Market
Omron Healthcare Welch Allyn, Inc.
A&D Medical Inc.;
American Diagnostics Corp.
Withings; Briggs Health
GE Healthcare; Kaz Inc.
Microlife AG
Rossmax International Ltd.
GF Health Products Inc.
Philips Healthcare;
Hill-Rom Servicee Inc.
Spacelabs Healthcare Inc,
Bosch & Sohn GmbH & Co. KG,
SunTech Medical, Schiller AG,
Welch Allyn Inc,
DAIFUKU CO. LTD,
GE Company,
Microlife Corporation,
Omron Healthcare Company,
Biobeat
"The quality of research they have done for us has been excellent..."